Humana (NYSE:HUM – Free Report) had its target price lowered by TD Cowen from $427.00 to $396.00 in a research report sent to investors on Tuesday, Benzinga reports. TD Cowen currently has a buy rating on the insurance provider’s stock. HUM has been the topic of several other research reports. Barclays initiated coverage on Humana […]